01801.HK
Innovent Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 81.60
+0.43%Forward multiples
Based on analyst estimates
- P/E forward
- 59.77x
- P/E 2026E
- 49.62x
- P/E 2027E
- 31.95x
- P/E 2028E
- 23.38x
- P/S forward
- 5.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- 97.90x
- PEG TTM
- 1.53x
- Price / book
- 3.04x
- Price / sales
- 4.04x
- Price / cash flow
- 4.70x
Enterprise value
- Enterprise value
- HKD 53.4B
- EV / sales
- 2.91x
- EV / EBITDA
- 17.83x
- EV / EBIT
- 24.19x
- Market cap
- HKD 74.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026